Story preview
Continue reading on the publisher site for the full article.
Read on publisher →Contract Pharma
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee
Coverage
Tone
Outlets covering it
11
in the last 3 days
First reported
3 days ago
10 outlets since
Countries
10 other outlets reported this story in the last 3 days.
Bayer has unveiled plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, U.S.
Bayer Plans $2.2 Billion Ohio Manufacturing Campus to Support Oncology and Cardiorenal Portfolio / Bayer, biotech, cancer, Cardiorenal Portfolio,
The investment will equip Bayer to make oncology, cardiovascular and renal care ingredients and drugs.